Pulmonary embolism (Q79954098)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094276%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Pulmonary embolism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094276%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Samuel Z Goldhaber

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094276%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094276%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094276%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094276%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

9417

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094276%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1295-1305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094276%20AND%20SRC:MED&resulttype=core&format=json

Clinical suspicion of fatal pulmonary embolism

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Hospital admission and mortality rates for venous thromboembolism in Oxford region, UK, 1975-98

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Clinical characteristics of acute pulmonary thromboembolism in Japan: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

The clinical course of pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Risk factors for venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Severe pulmonary embolism associated with air travel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

A prospective study of risk factors for pulmonary embolism in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Oral contraceptives and the risk of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Oral contraceptives and fatal pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Thrombosis in pregnancy: maternal and fetal issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Postmenopausal hormone replacement therapy: scientific review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Prognosis of Cancers Associated with Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Deep-vein thrombosis and the incidence of subsequent symptomatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Genetic susceptibility to venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

The antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

The Incidence of Venous Thromboembolism in Family Members of Patients with Factor V Leiden Mutation and Venous Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Upper-extremity deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Assessment of cardiac stress from massive pulmonary embolism with 12-lead ECG.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Imaging techniques in treatment algorithms of pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Alveolar-Arterial Oxygen Gradient in the Assessment of Acute Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Role of D-dimers in diagnosis of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Non-invasive diagnosis of venous thromboembolism in outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Value of transthoracic echocardiography in the diagnosis of pulmonary embolism: results of a prospective study in unselected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Complications and validity of pulmonary angiography in acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Clinical validity of a normal pulmonary angiogram in patients with suspected pulmonary embolism--a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Overview of Prospective Investigation of Pulmonary Embolism Diagnosis II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Echocardiography in the management of pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Prolonged antithrombin activity of low-molecular-weight heparins. Clinical implications for the treatment of thromboembolic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Temporal aspects of heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Delayed-onset heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

A randomized trial comparing 5-mg and 10-mg warfarin loading doses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Oral anticoagulation thresholds

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Thrombolysis for pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Thrombolytic therapy of pulmonary embolism: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Thrombolysis in submassive pulmonary embolism? No

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Transvenous catheter embolectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Acute pulmonary embolectomy: a contemporary approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Günther Tulip Retrievable Vena Cava Filter: results from the Registry of the Canadian Interventional Radiology Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

A Clinical Decision Support System for Prevention of Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

A computerized reminder system to increase the use of preventive care for hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Prevalence of Deep Venous Thrombosis Among Patients in Medical Intensive Care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Fondaparinux: a new synthetic pentasaccharide for thrombosis prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916004-2

7 January 2021

10.1016/S0140-6736(04)16004-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094276%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference